|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000129538 |
Summary for RNASE1 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000129538 | Gene symbol | RNASE1 |
| Gene name | ribonuclease A family member 1, pancreatic | |
| HGNC | 10044 | |
| Entrez ID | 6035 | |
| Gene type | protein_coding | |
| Synonyms | RNASE1|RAC1 | |
| UniProtAcc | P07998 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000129538 | RAC1 | DB00993 | Azathioprine | SmallMoleculeDrug |
| ENSG00000129538 | RAC1 | DB04315 | Guanosine-5'-Diphosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB00128 | Aspartic acid | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB00536 | Guanidine | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB01812 | Adenosine 3',5'-diphosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB01842 | 3'-Phosphate-Adenosine-5'-Diphosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB01942 | Formic acid | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB01961 | Cytidine 3'-monophosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB02098 | Adenosine-2'-5'-Diphosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB02363 | 2'-Monophosphoadenosine-5'-Diphosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB02573 | 2'-deoxycytidine-2'-deoxyadenosine-3',5'-monophosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB02714 | 3'-Uridinemonophosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB02805 | Arabinouridine 3'-phosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB02987 | Cysteine-S-acetamide | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03155 | 2'-fluoro-2'-deoxyuridine 3'-monophosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03186 | Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate] | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03326 | Deoxycytidylyl-3',5'-guanosine | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03447 | Uridylyl-2'-5'-phospho-adenosine | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03448 | 2'-Deoxyuridine 3'-Monophosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03512 | Uridine-2',3'-vanadate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03726 | Purine Riboside-5'-Monophosphate | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03765 | 2'-cytidylic acid | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03792 | 5-Aminouracil | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB03900 | tert-butanol | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB04272 | Citric acid | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB04464 | N-Formylmethionine | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB04514 | Uridylyl-2'-5'-phospho-guanosine | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB08596 | 5'-deoxy-5'-piperidin-1-ylthymidine | SmallMoleculeDrug |
| ENSG00000129538 | RNASE1 | DB08661 | 1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione | SmallMoleculeDrug |
| ENSG00000129538 | RAC1 | DB00514 | Dextromethorphan | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for RNASE1 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| RNASE1 | 2.19e+03 | 1.03e+00 | 2.66e-01 | 3.88e+00 | 1.05e-04 | 3.38e-04 | LIHC |
| RNASE1 | 7.33e+03 | -1.48e+00 | 1.11e-01 | -1.33e+01 | 1.23e-40 | 9.10e-40 | BRCA |
| RNASE1 | 4.72e+03 | -1.43e+00 | 4.21e-01 | -3.39e+00 | 6.95e-04 | 2.54e-03 | READ |
Top |
Sex-biased somatic mutation for RNASE1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
TCGA-HNSC |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
| ENSG00000129538 | HNSC | RAC1 | 4 | 8 | 4.44e-03 | 1.78e-01 | 6.79e-01 | 3.87e-02 | 4.04e-01 |
Top |
DNA methylation with beta values for RNASE1 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LIHC | cg13787135 | chr14:20802248 | CGI:chr14:20723387-20723701 | promoter,gene body | 4.26e-01 | 3.19e-01 | 3.44e+00 | 5.80e-04 | 2.54e-03 | 1.07e-01 |
| ACC | cg18832407 | chr14:20803196 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 5.73e-01 | 6.77e-01 | -2.13e+00 | 3.33e-02 | 4.30e-02 | -1.04e-01 |
| KICH | cg12940993 | chr14:20802989 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 8.00e-01 | 6.99e-01 | 2.26e+00 | 2.36e-02 | 3.96e-02 | 1.01e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg21908129 | chr14:20804373 | CGI:chr14:20723387-20723701 | promoter | 8.42e-01 | 9.48e-01 | -6.63e+00 | 3.44e-11 | 1.54e-09 | -1.06e-01 |
| LUSC | cg13787135 | chr14:20802248 | CGI:chr14:20723387-20723701 | promoter,gene body | 3.73e-01 | 2.53e-01 | 2.56e+00 | 1.04e-02 | 1.43e-02 | 1.20e-01 |
| LUSC | cg05153345 | chr14:20802416 | CGI:chr14:20723387-20723701 | promoter,gene body | 7.55e-01 | 4.94e-01 | 3.72e+00 | 2.02e-04 | 9.76e-04 | 2.60e-01 |
| LUSC | cg08122234 | chr14:20802691 | CGI:chr14:20723387-20723701 | promoter,gene body | 8.09e-01 | 5.15e-01 | 3.74e+00 | 1.81e-04 | 9.20e-04 | 2.93e-01 |
| LUSC | cg05958352 | chr14:20802765 | CGI:chr14:20723387-20723701 | promoter,gene body | 6.95e-01 | 4.73e-01 | 3.27e+00 | 1.08e-03 | 2.73e-03 | 2.23e-01 |
| LUSC | cg13718960 | chr14:20803154 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 6.24e-01 | 4.39e-01 | 3.15e+00 | 1.63e-03 | 3.62e-03 | 1.85e-01 |
| LUSC | cg18832407 | chr14:20803196 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 6.98e-01 | 4.76e-01 | 3.54e+00 | 3.97e-04 | 1.44e-03 | 2.22e-01 |
| LUSC | cg21908129 | chr14:20804373 | CGI:chr14:20723387-20723701 | promoter | 7.52e-01 | 9.37e-01 | -3.88e+00 | 1.04e-04 | 7.08e-04 | -1.85e-01 |
| COAD | cg13787135 | chr14:20802248 | CGI:chr14:20723387-20723701 | promoter,gene body | 2.21e-01 | 3.58e-01 | -4.48e+00 | 7.49e-06 | 4.75e-05 | -1.37e-01 |
| COAD | cg05958352 | chr14:20802765 | CGI:chr14:20723387-20723701 | promoter,gene body | 4.16e-01 | 5.34e-01 | -3.22e+00 | 1.30e-03 | 2.77e-03 | -1.18e-01 |
| COAD | cg18832407 | chr14:20803196 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 4.56e-01 | 6.04e-01 | -3.74e+00 | 1.87e-04 | 5.77e-04 | -1.48e-01 |
| BLCA | cg10197238 | chr14:20801585 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 4.49e-01 | 6.25e-01 | -3.00e+00 | 2.73e-03 | 5.02e-03 | -1.76e-01 |
| LIHC | cg13787135 | chr14:20802248 | CGI:chr14:20723387-20723701 | promoter,gene body | 3.19e-01 | 5.29e-01 | -4.57e+00 | 4.97e-06 | 1.49e-05 | -2.10e-01 |
| LIHC | cg08122234 | chr14:20802691 | CGI:chr14:20723387-20723701 | promoter,gene body | 5.87e-01 | 7.79e-01 | -2.70e+00 | 6.99e-03 | 8.88e-03 | -1.92e-01 |
| LIHC | cg05958352 | chr14:20802765 | CGI:chr14:20723387-20723701 | promoter,gene body | 5.98e-01 | 7.89e-01 | -3.53e+00 | 4.12e-04 | 7.22e-04 | -1.91e-01 |
| LIHC | cg18836485 | chr14:20802859 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 3.35e-01 | 5.25e-01 | -4.46e+00 | 8.31e-06 | 2.33e-05 | -1.90e-01 |
| LIHC | cg13718960 | chr14:20803154 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 4.48e-01 | 6.85e-01 | -5.43e+00 | 5.60e-08 | 3.25e-07 | -2.37e-01 |
| KIRP | cg13787135 | chr14:20802248 | CGI:chr14:20723387-20723701 | promoter,gene body | 7.32e-01 | 6.01e-01 | 4.16e+00 | 3.11e-05 | 9.70e-05 | 1.31e-01 |
| KIRP | cg05958352 | chr14:20802765 | CGI:chr14:20723387-20723701 | promoter,gene body | 9.15e-01 | 8.04e-01 | 6.08e+00 | 1.18e-09 | 5.17e-08 | 1.12e-01 |
| KIRP | cg18832407 | chr14:20803196 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 8.72e-01 | 7.68e-01 | 5.49e+00 | 4.06e-08 | 4.18e-07 | 1.03e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg18836485 | chr14:20802859 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 6.87e-01 | 5.11e-01 | 9.27e+00 | 1.85e-20 | 1.04e-19 | 1.77e-01 |
| BRCA | cg12940993 | chr14:20802989 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 5.58e-01 | 3.91e-01 | 9.60e+00 | 8.24e-22 | 5.21e-21 | 1.67e-01 |
| LUAD | cg05153345 | chr14:20802416 | CGI:chr14:20723387-20723701 | promoter,gene body | 5.76e-01 | 4.75e-01 | 2.10e+00 | 3.56e-02 | 3.91e-02 | 1.01e-01 |
| HNSC | cg08122234 | chr14:20802691 | CGI:chr14:20723387-20723701 | promoter,gene body | 8.26e-01 | 9.32e-01 | -2.15e+00 | 3.16e-02 | 3.67e-02 | -1.06e-01 |
| BLCA | cg08122234 | chr14:20802691 | CGI:chr14:20723387-20723701 | promoter,gene body | 6.96e-01 | 8.48e-01 | -2.01e+00 | 4.46e-02 | 4.61e-02 | -1.52e-01 |
| BLCA | cg18836485 | chr14:20802859 | CGI:chr14:20723387-20723701 | UTR,promoter,exon,gene body | 3.26e-01 | 4.74e-01 | -2.39e+00 | 1.70e-02 | 2.44e-02 | -1.48e-01 |
Top |
Exon skipping events with PSI in TCGA for RNASE1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for RNASE1 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for RNASE1 |
TFs related to RNASE1.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | KLF10 | RNASE1 | 2.97e+00 | 3.02e-03 | 4.56e+00 | 9.88e-01 | Female-biased |
| BRCA | KLF17 | RNASE1 | 3.36e+00 | 6.00e-03 | 4.73e+00 | 9.87e-01 | Female-biased |
| BRCA | RBAK | RNASE1 | 3.09e+00 | 6.16e-03 | 4.45e+00 | 9.83e-01 | Female-biased |
| BRCA | SPZ1 | RNASE1 | 3.37e+00 | 5.16e-03 | 4.79e+00 | 9.89e-01 | Female-biased |
| BRCA | TFAP4 | RNASE1 | 3.41e+00 | 8.34e-03 | 4.69e+00 | 9.85e-01 | Female-biased |
| BRCA | ZIM2 | RNASE1 | 3.01e+00 | 4.58e-03 | 4.47e+00 | 9.85e-01 | Female-biased |
| BRCA | ZNF17 | RNASE1 | 3.34e+00 | 7.05e-03 | 4.67e+00 | 9.86e-01 | Female-biased |
| BRCA | ZNF320 | RNASE1 | 3.21e+00 | 4.95e-03 | 4.65e+00 | 9.88e-01 | Female-biased |
| BRCA | ZNF322 | RNASE1 | 3.16e+00 | 5.48e-03 | 4.56e+00 | 9.86e-01 | Female-biased |
| BRCA | ZNF394 | RNASE1 | 3.06e+00 | 4.29e-03 | 4.54e+00 | 9.87e-01 | Female-biased |
| BRCA | ZNF436 | RNASE1 | 3.21e+00 | 4.78e-03 | 4.66e+00 | 9.88e-01 | Female-biased |
| BRCA | ZNF468 | RNASE1 | 3.15e+00 | 6.68e-03 | 4.49e+00 | 9.83e-01 | Female-biased |
| BRCA | ZNF483 | RNASE1 | 3.28e+00 | 8.43e-03 | 4.55e+00 | 9.82e-01 | Female-biased |
| BRCA | ZNF506 | RNASE1 | 3.46e+00 | 7.20e-03 | 4.78e+00 | 9.87e-01 | Female-biased |
| BRCA | ZNF543 | RNASE1 | 2.87e+00 | 4.53e-03 | 4.32e+00 | 9.82e-01 | Female-biased |
| BRCA | ZNF605 | RNASE1 | 3.62e+00 | 8.90e-03 | 4.87e+00 | 9.86e-01 | Female-biased |
| BRCA | ZNF692 | RNASE1 | 3.47e+00 | 6.42e-03 | 4.82e+00 | 9.88e-01 | Female-biased |
| MESO | ZNF320 | RNASE1 | 3.07e+00 | 7.92e-03 | 4.41e+00 | 9.84e-01 | Female-biased |
| MESO | ZNF468 | RNASE1 | 2.89e+00 | 8.02e-03 | 4.22e+00 | 9.81e-01 | Female-biased |
| SARC | SPZ1 | RNASE1 | 4.45e+00 | 9.82e-01 | 3.89e+00 | 1.00e-02 | Male-biased |
| SARC | ZIM2 | RNASE1 | 4.26e+00 | 9.83e-01 | 3.62e+00 | 5.89e-03 | Male-biased |
| SARC | ZNF311 | RNASE1 | 4.03e+00 | 9.80e-01 | 3.33e+00 | 4.22e-03 | Male-biased |
| SARC | ZNF320 | RNASE1 | 4.33e+00 | 9.83e-01 | 3.71e+00 | 6.93e-03 | Male-biased |
| SARC | ZNF543 | RNASE1 | 4.16e+00 | 9.83e-01 | 3.49e+00 | 4.81e-03 | Male-biased |
RNASE1 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for RNASE1 |
RBPs related to ES in RNASE1.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CHOL | PCBP2 | exon_skip_111021 | 6.08e+00 | 9.62e-04 | 6.84e+00 | 9.84e-01 | Female-biased |
| THCA | PCBP2 | exon_skip_111023 | 6.48e+00 | 4.16e-03 | 6.84e+00 | 9.81e-01 | Female-biased |
| THCA | SRSF9 | exon_skip_111021 | 6.38e+00 | 1.15e-03 | 6.86e+00 | 9.84e-01 | Female-biased |
| PCPG | SRSF9 | exon_skip_111023 | 6.42e+00 | 2.96e-03 | 6.84e+00 | 9.82e-01 | Female-biased |
RNASE1 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10148089 | chr14:21682101:C:A | - | -0.267116970451433 | 8.51739329778032e-05 | GBM | Female-baised eQTL |
| rs12436339 | chr14:21681997:C:T | - | -0.224446243317886 | 0.00323533876659838 | GBM | Female-baised eQTL |
| rs35505349 | chr14:25162311:A:G | - | 0.102328404742757 | 0.0486376891574388 | STAD | Female-baised eQTL |
| rs2236260 | chr14:23475296:G:A | - | -0.0902549254794603 | 0.0110022068285415 | LGG | Female-baised eQTL |
| rs369653636 | chr14:23453435:T:A | - | -0.0889067381027805 | 0.0147125526033472 | LGG | Female-baised eQTL |
| rs373566161 | chr14:23453436:A:G | - | -0.0889067381027805 | 0.0147125526033472 | LGG | Female-baised eQTL |
| rs202096969 | chr14:23453437:A:C | - | -0.0889067381027805 | 0.0147125526033472 | LGG | Female-baised eQTL |
| rs7158784 | chr14:23478293:T:C | - | -0.0896508916145871 | 0.0154104845200756 | LGG | Female-baised eQTL |
| rs4048658 | chr14:23480150:C:A | - | -0.0896508916145871 | 0.0154104845200756 | LGG | Female-baised eQTL |
| rs10131725 | chr14:23473179:A:G | - | -0.0863157101398498 | 0.0182670915493199 | LGG | Female-baised eQTL |
| rs7154379 | chr14:23474709:G:A | - | -0.0863157101398498 | 0.0182670915493199 | LGG | Female-baised eQTL |
| rs6573195 | chr14:23474811:A:G | - | -0.0863157101398498 | 0.0182670915493199 | LGG | Female-baised eQTL |
| rs2145566 | chr14:23452701:C:T | - | -0.0853558136700053 | 0.0221250291109662 | LGG | Female-baised eQTL |
| rs111320504 | chr14:28997263:A:G | - | 0.190815269259983 | 0.0377702555442077 | LGG | Female-baised eQTL |
| rs77093910 | chr14:28868025:C:T | - | 0.185913270298836 | 0.0391094534190095 | LGG | Female-baised eQTL |
| rs75759890 | chr14:28860291:G:A | - | 0.183862560391961 | 0.0449803681603927 | LGG | Female-baised eQTL |
| rs222607 | chr14:23646515:T:C | - | -0.170687053010852 | 0.00023567431450407 | BLCA | Female-baised eQTL |
| rs9972278 | chr14:23099285:C:T | - | 0.16147131463989 | 0.000564519267453979 | BLCA | Female-baised eQTL |
| rs45532441 | chr14:29627839:C:T | - | 0.16322412050356 | 0.000653083194526985 | BLCA | Female-baised eQTL |
| rs11623171 | chr14:29629710:T:C | - | 0.16322412050356 | 0.000653083194526985 | BLCA | Female-baised eQTL |
| rs73253368 | chr14:29609645:A:G | - | 0.160573607430727 | 0.000776670021733574 | BLCA | Female-baised eQTL |
| rs17652711 | chr14:29609083:C:T | - | 0.158141886214583 | 0.00107401496858577 | BLCA | Female-baised eQTL |
| rs12892543 | chr14:29762072:G:C | - | 0.147279431559242 | 0.00173130200987046 | BLCA | Female-baised eQTL |
| rs10150613 | chr14:29618415:C:A | - | 0.151672665098974 | 0.00217344074696496 | BLCA | Female-baised eQTL |
| rs35784769 | chr14:29751999:A:G | - | 0.144300518037492 | 0.00217875437475678 | BLCA | Female-baised eQTL |
| rs12896582 | chr14:29753897:C:G | - | 0.143980148111385 | 0.00237367987332078 | BLCA | Female-baised eQTL |
| rs17478506 | chr14:29755506:T:C | - | 0.143980148111385 | 0.00237367987332078 | BLCA | Female-baised eQTL |
| rs61978035 | chr14:29748145:T:G | - | 0.141831851327344 | 0.00275936230031889 | BLCA | Female-baised eQTL |
| rs35060633 | chr14:29744531:T:C | - | 0.141345260164452 | 0.00286518942013491 | BLCA | Female-baised eQTL |
| rs12896362 | chr14:29745423:A:G | - | 0.141345260164452 | 0.00286518942013491 | BLCA | Female-baised eQTL |
| rs12897251 | chr14:29745666:G:A | - | 0.141345260164452 | 0.00286518942013491 | BLCA | Female-baised eQTL |
| rs16895 | chr14:29605117:G:A | - | 0.147013347368941 | 0.00338324214572344 | BLCA | Female-baised eQTL |
| rs4981057 | chr14:29739781:T:C | - | 0.140193305128335 | 0.00340926478632694 | BLCA | Female-baised eQTL |
| rs12878332 | chr14:29739912:T:A | - | 0.140193305128335 | 0.00340926478632694 | BLCA | Female-baised eQTL |
| rs12879046 | chr14:29740339:T:C | - | 0.140193305128335 | 0.00340926478632694 | BLCA | Female-baised eQTL |
| rs12878274 | chr14:29740425:G:A | - | 0.140193305128335 | 0.00340926478632694 | BLCA | Female-baised eQTL |
| rs12878120 | chr14:29724102:T:A | - | 0.139806277867205 | 0.00349958435331419 | BLCA | Female-baised eQTL |
| rs10498310 | chr14:29724940:C:T | - | 0.139806277867205 | 0.00349958435331419 | BLCA | Female-baised eQTL |
| rs17386482 | chr14:29735922:A:G | - | 0.139806277867205 | 0.00349958435331419 | BLCA | Female-baised eQTL |
| rs2877986 | chr14:29737393:G:A | - | 0.139806277867205 | 0.00349958435331419 | BLCA | Female-baised eQTL |
| rs12893992 | chr14:29757163:A:G | - | 0.139441406330092 | 0.00368112618666353 | BLCA | Female-baised eQTL |
| rs34297732 | chr14:29741861:A:T | - | 0.138953394447897 | 0.00369352242654224 | BLCA | Female-baised eQTL |
| rs2333627 | chr14:29745232:C:T | - | 0.138514543402765 | 0.00379155223492583 | BLCA | Female-baised eQTL |
| rs72660540 | chr14:28250873:C:T | - | 0.267515335893718 | 0.00413571484595245 | BLCA | Female-baised eQTL |
| rs1953730 | chr14:29736606:G:C | - | 0.143037601433497 | 0.00457004260673779 | BLCA | Female-baised eQTL |
| rs12589290 | chr14:21265298:A:G | - | 0.130748139502531 | 0.00479898460180144 | BLCA | Female-baised eQTL |
| rs118140701 | chr14:21266241:T:C | - | 0.130748139502531 | 0.00479898460180144 | BLCA | Female-baised eQTL |
| rs74693625 | chr14:21267556:A:T | - | 0.130748139502531 | 0.00479898460180144 | BLCA | Female-baised eQTL |
| rs12892645 | chr14:29762325:C:T | - | 0.133828868648196 | 0.00544719097238146 | BLCA | Female-baised eQTL |
| rs45617646 | chr14:29762636:T:C | - | 0.133383706785582 | 0.00563614701331364 | BLCA | Female-baised eQTL |
| rs875677 | chr14:29602115:C:T | - | 0.141651613240788 | 0.00617840488541784 | BLCA | Female-baised eQTL |
| rs143893377 | chr14:20864204:G:A | - | 0.13230622182942 | 0.00646527292478252 | BLCA | Female-baised eQTL |
| rs34225298 | chr14:29814659:C:G | - | 0.131461561927345 | 0.00654586471526851 | BLCA | Female-baised eQTL |
| rs140507447 | chr14:20861871:C:T | - | 0.13186286662164 | 0.00660151263215917 | BLCA | Female-baised eQTL |
| rs7161131 | chr14:29762900:C:T | - | 0.130867730976732 | 0.00743144165127573 | BLCA | Female-baised eQTL |
| rs7161324 | chr14:29762995:C:T | - | 0.130867730976732 | 0.00743144165127573 | BLCA | Female-baised eQTL |
| rs11850756 | chr14:29760199:A:G | - | 0.133587807067676 | 0.00787092916025857 | BLCA | Female-baised eQTL |
| rs954455 | chr14:29745221:T:C | - | 0.128506554341987 | 0.00842342639318629 | BLCA | Female-baised eQTL |
| rs35588647 | chr14:29727200:A:T | - | 0.131066537008547 | 0.00934389514686555 | BLCA | Female-baised eQTL |
| rs12897784 | chr14:29770083:G:A | - | 0.127761562690925 | 0.00935058236210468 | BLCA | Female-baised eQTL |
| rs1953719 | chr14:29770303:C:G | - | 0.127761562690925 | 0.00935058236210468 | BLCA | Female-baised eQTL |
| rs1959438 | chr14:29771891:A:G | - | 0.127761562690925 | 0.00935058236210468 | BLCA | Female-baised eQTL |
| rs35975962 | chr14:29772442:A:C | - | 0.127761562690925 | 0.00935058236210468 | BLCA | Female-baised eQTL |
| rs946014 | chr14:29774790:G:A | - | 0.127761562690925 | 0.00935058236210468 | BLCA | Female-baised eQTL |
| rs35786792 | chr14:29775565:G:C | - | 0.127761562690925 | 0.00935058236210468 | BLCA | Female-baised eQTL |
| rs36045242 | chr14:29776073:C:T | - | 0.127761562690925 | 0.00935058236210468 | BLCA | Female-baised eQTL |
| rs34636441 | chr14:29764919:T:C | - | 0.128041960444668 | 0.00952591199635453 | BLCA | Female-baised eQTL |
| rs1953720 | chr14:29767070:A:C | - | 0.128041960444668 | 0.00952591199635453 | BLCA | Female-baised eQTL |
| rs1953729 | chr14:29741616:C:T | - | 0.12995597319725 | 0.00974774971892727 | BLCA | Female-baised eQTL |
| rs35123683 | chr14:29776212:G:A | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs142204660 | chr14:29776472:C:A | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs117815773 | chr14:29776622:G:C | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs139672554 | chr14:29776805:C:T | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs139256757 | chr14:29778079:T:A | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs76364827 | chr14:29778386:A:G | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs61979962 | chr14:29786738:G:A | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs12879750 | chr14:29788371:C:A | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs34510700 | chr14:29807041:A:T | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs7154546 | chr14:29810777:G:A | - | 0.127611643693158 | 0.00979794224014963 | BLCA | Female-baised eQTL |
| rs2333628 | chr14:29764192:C:T | - | 0.127585297978729 | 0.00983489771584444 | BLCA | Female-baised eQTL |
| rs12895018 | chr14:29765959:G:T | - | 0.127585297978729 | 0.00983489771584444 | BLCA | Female-baised eQTL |
| rs17478638 | chr14:29766728:G:A | - | 0.127585297978729 | 0.00983489771584444 | BLCA | Female-baised eQTL |
| rs12886559 | chr14:29768554:A:C | - | 0.127585297978729 | 0.00983489771584444 | BLCA | Female-baised eQTL |
| rs12891897 | chr14:29769183:A:G | - | 0.127585297978729 | 0.00983489771584444 | BLCA | Female-baised eQTL |
| rs7161700 | chr14:29763289:A:T | - | 0.127891792408508 | 0.0100024493838083 | BLCA | Female-baised eQTL |
| rs79822628 | chr14:29780064:T:C | - | 0.127891792408508 | 0.0100024493838083 | BLCA | Female-baised eQTL |
| rs34946569 | chr14:29783935:A:G | - | 0.127891792408508 | 0.0100024493838083 | BLCA | Female-baised eQTL |
| rs61979961 | chr14:29785404:C:T | - | 0.127891792408508 | 0.0100024493838083 | BLCA | Female-baised eQTL |
| rs56283845 | chr14:29788854:T:C | - | 0.127891792408508 | 0.0100024493838083 | BLCA | Female-baised eQTL |
| rs2333630 | chr14:29803914:G:A | - | 0.127891792408508 | 0.0100024493838083 | BLCA | Female-baised eQTL |
| rs10498309 | chr14:29724683:C:G | - | 0.129921492033139 | 0.0101345190233189 | BLCA | Female-baised eQTL |
| rs11626603 | chr14:29725693:T:C | - | 0.129921492033139 | 0.0101345190233189 | BLCA | Female-baised eQTL |
| rs35203886 | chr14:29728518:C:A | - | 0.129921492033139 | 0.0101345190233189 | BLCA | Female-baised eQTL |
| rs145819288 | chr14:20863665:A:G | - | 0.130600911094418 | 0.0101929550940787 | BLCA | Female-baised eQTL |
| rs8009479 | chr14:21235305:A:T | - | 0.120877205616507 | 0.0108076360362495 | BLCA | Female-baised eQTL |
| rs72675010 | chr14:21218130:T:G | - | 0.119602458861308 | 0.0112890833700881 | BLCA | Female-baised eQTL |
| rs10658793 | chr14:21251641:C:T | - | 0.120756781736833 | 0.011385989873731 | BLCA | Female-baised eQTL |
| rs12185018 | chr14:21259407:A:T | - | 0.120756781736833 | 0.011385989873731 | BLCA | Female-baised eQTL |
| rs8012227 | chr14:21239644:C:T | - | 0.120707887942079 | 0.0114625129562647 | BLCA | Female-baised eQTL |
| rs72675020 | chr14:21242399:G:A | - | 0.120707887942079 | 0.0114625129562647 | BLCA | Female-baised eQTL |
| rs68014001 | chr14:20857125:C:G | - | 0.128953872328829 | 0.0114656141585544 | BLCA | Female-baised eQTL |
| rs17386746 | chr14:29740159:G:A | - | 0.128825491350811 | 0.0116646282802033 | BLCA | Female-baised eQTL |
| rs12885125 | chr14:29728931:G:A | - | 0.128398936989787 | 0.0119246826868619 | BLCA | Female-baised eQTL |
| rs12886946 | chr14:29729389:T:A | - | 0.128398936989787 | 0.0119246826868619 | BLCA | Female-baised eQTL |
| rs11627369 | chr14:29731495:T:C | - | 0.128398936989787 | 0.0119246826868619 | BLCA | Female-baised eQTL |
| rs17477600 | chr14:29733027:G:C | - | 0.128398936989787 | 0.0119246826868619 | BLCA | Female-baised eQTL |
| rs4981056 | chr14:29733871:G:T | - | 0.128398936989787 | 0.0119246826868619 | BLCA | Female-baised eQTL |
| rs11628675 | chr14:29735909:A:T | - | 0.128398936989787 | 0.0119246826868619 | BLCA | Female-baised eQTL |
| rs4996739 | chr14:29737011:A:T | - | 0.128398936989787 | 0.0119246826868619 | BLCA | Female-baised eQTL |
| rs4627232 | chr14:29737691:G:C | - | 0.128398936989787 | 0.0119246826868619 | BLCA | Female-baised eQTL |
| rs200250829 | chr14:20865337:G:T | - | 0.123207491891908 | 0.0120325514973128 | BLCA | Female-baised eQTL |
| rs146168728 | chr14:20863275:G:A | - | 0.128279559585096 | 0.0120493429881486 | BLCA | Female-baised eQTL |
| rs17096040 | chr14:29752442:C:T | - | 0.127742912157153 | 0.0122602120771218 | BLCA | Female-baised eQTL |
| rs11627841 | chr14:29752761:C:A | - | 0.127742912157153 | 0.0122602120771218 | BLCA | Female-baised eQTL |
| rs7155235 | chr14:29753578:C:G | - | 0.127742912157153 | 0.0122602120771218 | BLCA | Female-baised eQTL |
| rs11851845 | chr14:29753791:A:G | - | 0.127742912157153 | 0.0122602120771218 | BLCA | Female-baised eQTL |
| rs11848031 | chr14:29753792:T:C | - | 0.127742912157153 | 0.0122602120771218 | BLCA | Female-baised eQTL |
| rs3790069 | chr14:21225226:G:C | - | 0.11944875709338 | 0.0122745015716562 | BLCA | Female-baised eQTL |
| rs72675015 | chr14:21226435:G:T | - | 0.11944875709338 | 0.0122745015716562 | BLCA | Female-baised eQTL |
| rs7147840 | chr14:21229699:T:C | - | 0.11944875709338 | 0.0122745015716562 | BLCA | Female-baised eQTL |
| rs4981716 | chr14:29739817:G:A | - | 0.127789841467261 | 0.0124949498936712 | BLCA | Female-baised eQTL |
| rs12889453 | chr14:29735003:G:A | - | 0.127347351000867 | 0.012805053018501 | BLCA | Female-baised eQTL |
| rs1953728 | chr14:29741787:T:A | - | 0.127265463387132 | 0.0129300620161143 | BLCA | Female-baised eQTL |
| rs1953727 | chr14:29741880:G:T | - | 0.127265463387132 | 0.0129300620161143 | BLCA | Female-baised eQTL |
| rs1953723 | chr14:29761297:G:T | - | 0.1290402863071 | 0.0130569774914772 | BLCA | Female-baised eQTL |
| rs7161139 | chr14:29754294:G:A | - | 0.127419533790973 | 0.0132269377818575 | BLCA | Female-baised eQTL |
| rs17096052 | chr14:29754554:A:C | - | 0.127419533790973 | 0.0132269377818575 | BLCA | Female-baised eQTL |
| rs17096055 | chr14:29754874:T:C | - | 0.127419533790973 | 0.0132269377818575 | BLCA | Female-baised eQTL |
| rs1953724 | chr14:29755493:C:T | - | 0.127419533790973 | 0.0132269377818575 | BLCA | Female-baised eQTL |
| rs45581638 | chr14:29757356:G:A | - | 0.127419533790973 | 0.0132269377818575 | BLCA | Female-baised eQTL |
| rs45520241 | chr14:29757629:A:G | - | 0.127419533790973 | 0.0132269377818575 | BLCA | Female-baised eQTL |
| rs7141487 | chr14:29757992:C:T | - | 0.127419533790973 | 0.0132269377818575 | BLCA | Female-baised eQTL |
| rs11848573 | chr14:29758604:C:G | - | 0.127419533790973 | 0.0132269377818575 | BLCA | Female-baised eQTL |
| rs45462599 | chr14:29796373:C:T | - | 0.125015246186974 | 0.0132330562396672 | BLCA | Female-baised eQTL |
| rs72662593 | chr14:28422646:G:C | - | 0.223362143552806 | 0.0136695002928218 | BLCA | Female-baised eQTL |
| rs35811677 | chr14:29726260:T:C | - | 0.126088482464482 | 0.0146806637042966 | BLCA | Female-baised eQTL |
| rs11622170 | chr14:29750580:C:A | - | 0.12535682373528 | 0.015281464823117 | BLCA | Female-baised eQTL |
| rs946016 | chr14:29750964:A:G | - | 0.12535682373528 | 0.015281464823117 | BLCA | Female-baised eQTL |
| rs8016099 | chr14:21230910:A:C | - | 0.113316258568648 | 0.015947823038975 | BLCA | Female-baised eQTL |
| rs72677347 | chr14:28216300:T:C | - | 0.208057290725711 | 0.0161396182098414 | BLCA | Female-baised eQTL |
| rs118178425 | chr14:28209775:G:A | - | 0.207800089488594 | 0.0162538791770792 | BLCA | Female-baised eQTL |
| rs145413046 | chr14:28212512:G:A | - | 0.207800089488594 | 0.0162538791770792 | BLCA | Female-baised eQTL |
| rs12886195 | chr14:29728969:T:C | - | 0.123705627306584 | 0.018030218537586 | BLCA | Female-baised eQTL |
| rs11627865 | chr14:29729979:C:T | - | 0.123705627306584 | 0.018030218537586 | BLCA | Female-baised eQTL |
| rs11622611 | chr14:29731323:A:G | - | 0.123705627306584 | 0.018030218537586 | BLCA | Female-baised eQTL |
| rs11627494 | chr14:29734819:G:A | - | 0.123705627306584 | 0.018030218537586 | BLCA | Female-baised eQTL |
| rs8008575 | chr14:29746531:T:C | - | 0.122819466330034 | 0.0191767865330266 | BLCA | Female-baised eQTL |
| rs8003617 | chr14:29749213:C:T | - | 0.123388068469665 | 0.0193346618996976 | BLCA | Female-baised eQTL |
| rs77677655 | chr14:20660782:C:T | - | 0.224910653310886 | 0.0206813354536423 | BLCA | Female-baised eQTL |
| rs72659950 | chr14:20656258:G:A | - | 0.224392128561163 | 0.0216826684802378 | BLCA | Female-baised eQTL |
| rs74560903 | chr14:20864838:C:T | - | 0.117076572012798 | 0.0219798618711978 | BLCA | Female-baised eQTL |
| rs10147276 | chr14:28368695:A:G | - | 0.209969199459986 | 0.0222643817274411 | BLCA | Female-baised eQTL |
| rs12323487 | chr14:28368565:C:A | - | 0.209795433924198 | 0.0222857063165634 | BLCA | Female-baised eQTL |
| rs7158651 | chr14:28371208:C:T | - | 0.209795433924198 | 0.0222857063165634 | BLCA | Female-baised eQTL |
| rs28535446 | chr14:28374667:A:T | - | 0.209795433924198 | 0.0222857063165634 | BLCA | Female-baised eQTL |
| rs873949 | chr14:29774643:G:C | - | 0.119977396972145 | 0.0226457892532954 | BLCA | Female-baised eQTL |
| rs144438210 | chr14:29779001:G:A | - | 0.119977396972145 | 0.0226457892532954 | BLCA | Female-baised eQTL |
| rs61979963 | chr14:29786744:C:T | - | 0.119282580154645 | 0.0228677643139468 | BLCA | Female-baised eQTL |
| rs28758807 | chr14:30052272:C:A | - | 0.166073555442447 | 0.0270422739552236 | BLCA | Female-baised eQTL |
| rs34730223 | chr14:30049978:G:A | - | 0.165685582717231 | 0.0275490298670765 | BLCA | Female-baised eQTL |
| rs1956802 | chr14:25664764:C:G | - | -0.108595542065453 | 0.0316071762755486 | BLCA | Female-baised eQTL |
| rs10873327 | chr14:25663854:T:G | - | -0.107907457160343 | 0.0330674000730579 | BLCA | Female-baised eQTL |
| rs11156891 | chr14:21223782:T:A | - | 0.107912687975739 | 0.0337274403425943 | BLCA | Female-baised eQTL |
| rs10131751 | chr14:28212010:C:A | - | 0.191637183287894 | 0.0348440116438892 | BLCA | Female-baised eQTL |
| rs55856833 | chr14:28213454:G:A | - | 0.191637183287894 | 0.0348440116438892 | BLCA | Female-baised eQTL |
| rs10139961 | chr14:29775753:C:T | - | 0.115394207492142 | 0.0352940198890807 | BLCA | Female-baised eQTL |
| rs34727566 | chr14:29776019:G:A | - | 0.115394207492142 | 0.0352940198890807 | BLCA | Female-baised eQTL |
| rs144346019 | chr14:29779162:A:C | - | 0.115761775173427 | 0.035871444705652 | BLCA | Female-baised eQTL |
| rs9671293 | chr14:25661590:A:G | - | -0.108464471384189 | 0.0359152502863448 | BLCA | Female-baised eQTL |
| rs41449149 | chr14:30056395:C:T | - | 0.161309650392298 | 0.0403705138583997 | BLCA | Female-baised eQTL |
| rs58830349 | chr14:20488853:G:C | - | 0.106970496790312 | 0.0412777093935953 | BLCA | Female-baised eQTL |
| rs2781351 | chr14:29829568:C:T | - | -0.105365838390368 | 0.042667405479999 | BLCA | Female-baised eQTL |
| rs12896375 | chr14:29766263:T:A | - | 0.112244120944489 | 0.0431450043516984 | BLCA | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs72667873 | chr14:28663277:A:G | - | 0.147562651346728 | 0.0398415606997138 | KIRP | Male-baised eQTL |
| rs10134186 | chr14:26303022:C:T | - | -0.106290252576094 | 0.0073511385008218 | KIRC | Male-baised eQTL |
| rs962375 | chr14:26301667:T:C | - | -0.105900574082304 | 0.00777329094728408 | KIRC | Male-baised eQTL |
| rs139827864 | chr14:26298224:A:G | - | -0.0969585253621669 | 0.0185444860699296 | KIRC | Male-baised eQTL |
| rs1950853 | chr14:26300885:T:A | - | -0.0943248163848376 | 0.0222994446511835 | KIRC | Male-baised eQTL |
| rs1956478 | chr14:26289745:C:T | - | -0.0905310041386272 | 0.0361661560639684 | KIRC | Male-baised eQTL |
| rs1956477 | chr14:26289816:C:T | - | -0.0905310041386272 | 0.0361661560639684 | KIRC | Male-baised eQTL |
| rs7157378 | chr14:26290477:C:T | - | -0.0905310041386272 | 0.0361661560639684 | KIRC | Male-baised eQTL |
| rs7159154 | chr14:26292334:A:G | - | -0.0905310041386272 | 0.0361661560639684 | KIRC | Male-baised eQTL |
| rs1824576 | chr14:25229512:G:A | - | 0.118202906247949 | 0.039473996389354 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Gene ID: ENSG00000129538 | |
| CpG Site: cg08122234 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.435725678149286 | |
| Female Effect: - |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg08122234 | chr14:20802691 | gene,promoter | -0.435725678149286 | 8.64844597145124e-06 | -0.3784778355333682 | 3.027283561807374e-08 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of RNASE1 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |